GLP-1 Receptor Agonists and Risk for Cirrhosis and Related C...

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

PubMed pubmed.ncbi.nlm.nih.gov

RelatedInsightsHighlights

Thumbnail of www-x-com-duedoctor-status-1950872796050968961-8db5b63bf7974f7d

BREAKING: ELI LILLY REPORTS PHASE 3 HEAD TO HEAD RESULTS VS TRULICITY (DULAGLUTIDE) $LLY BEATS $LLY https://t.co/BMnRyxVXGa

DoctorDueDiligence

x.com

The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Purchases

papers.ssrn.com

Thumbnail of www-x-com-cremieuxrecueil-status-1955377889891008619-058aa8d05ed947d0

Why do GLP-1 drugs like Ozempic seem to fix so many different outcomes? I just read a clever study that might help us find the answer🧵 The method they used was good ole Mendelian Randomization! https://t.co/7bdKWJm3Rc

Crémieux

x.com